Characterization of a novel marine microbial uricase from Priestia flexa and evaluation of the effects of CMCS conjugation on its enzymatic properties

• Published in: Preparative biochemistry & biotechnology Vol. 53; no. 7; pp. 816 - 826
• Main Authors: Jiao, YuLiang, Zhu, YuYing, Zeng, ShuMin, Wang, ShuFang, Chen, Jing, Zhou, XiangHong, Ma, GuiZhen
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 2023; Taylor & Francis Ltd
• Subjects: Biomedical research; Body temperature; Carboxymethylchitosan (CMCS); Chitosan; Conjugation; Enzymes; enzymological properties; Gram-positive bacteria; Intestine; Marine ecology; Metabolism; Microorganisms; Oral administration; pH effects; Priestia flexa alkaAU; rRNA 16S; Small intestine; Urate oxidase; Uric acid; uricase (urate oxidase); Carboxymethylchitosan (CMCS); enzymological properties; uricase (urate oxidase); Priestia flexa alkaAU; conjugation
• ISSN: 1082-6068; 1532-2297
• DOI: 10.1080/10826068.2022.2145611

A novel uricase producing marine bacterium Priestia flexa alkaAU was isolated and identified. The 16S rDNA and the uricase coding gene were sequenced, analyzed and submitted to GenBank. The uricase from Priestia flexa alkaAU (PFU) was purified, determined to be 58.87 kDa, and conjugated with carboxymethyl chitosan (CMCS) by ionic gelation. CMCS conjugation had no effect on the optimum pH of PFU but decreased the optimum temperature by 10 °C. CMCS conjugation increased the specific activity of PFU by 53% at the human body temperature (37 °C) and small intestine's pH (pH 6.8). Uricase thermostabilizing ability of CMCS was significant in the range of 37-80 °C but not at lower temperatures. For improvement of the pH stability of PFU, CMCS was more effective at pHs 3-5 than pHs 6-11. CMCS increased the half-life of PFU against artificial intestinal fluid by 1.5 folds, which demonstrated the potential capability of CMCS-PFU for oral administration.